Safety of Low-Dose Aprotinin in Coronary Artery Bypass Graft Surgery

[1]  R. Martineau,et al.  A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. , 2008, The New England journal of medicine.

[2]  L. Hiratzka,et al.  Aprotinin Does Not Increase the Risk of Renal Failure in Cardiac Surgery Patients , 2007, Circulation.

[3]  Jeremiah R. Brown,et al.  Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Antifibrinolytic Agents in Cardiac Surgery , 2007, Circulation.

[4]  C. White,et al.  Evaluating the safety implications of aprotinin use: the Retrospective Evaluation of Aprotinin in Cardio Thoracic Surgery (REACTS). , 2007, The Journal of thoracic and cardiovascular surgery.

[5]  A. Hoeft,et al.  Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. , 2007, JAMA.

[6]  T. Ferguson.  Aprotinin--are there lessons learned? , 2007, JAMA.

[7]  W. Hiatt.  Observational studies of drug safety--aprotinin and the absence of transparency. , 2006, The New England journal of medicine.

[8]  S. Body,et al.  Full-Dose Aprotinin Use in Coronary Artery Bypass Graft Surgery: An Analysis of Perioperative Pharmacotherapy and Patient Outcomes , 2006, Anesthesia and analgesia.

[9]  J. Elefteriades,et al.  Aprotinin use in thoracic aortic surgery: safety and outcomes. , 2006, The Journal of thoracic and cardiovascular surgery.

[10]  Keyvan Karkouti,et al.  A propensity score case‐control comparison of aprotinin and tranexamic acid in high‐transfusion‐risk cardiac surgery , 2006, Transfusion.

[11]  I. C. Tudor,et al.  The risk associated with aprotinin in cardiac surgery. , 2006, The New England journal of medicine.

[12]  J. Gummert,et al.  Cardiac surgery in Germany during 2004: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. , 2005, The Thoracic and cardiovascular surgeon.

[13]  J. Hammon,et al.  Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery? , 2005, The Annals of thoracic surgery.

[14]  T. Treasure,et al.  Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. , 2004, The Journal of thoracic and cardiovascular surgery.

[15]  J. Fontcuberta,et al.  The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss. , 2000, Haematologica.

[16]  D. Roberts,et al.  Factors influencing haemostasis and blood transfusion in cardiac surgery , 1996, Perfusion.

[17]  E. Berreklouw,et al.  Low-dose aprotinin in internal mammary artery bypass operations contributes to important blood saving. , 1992, The Annals of thoracic surgery.